[Code of Federal Regulations] [Title 21, Volume 9] [Revised as of April 1, 2001] From the U.S. Government Printing Office via GPO Access [CITE: 21CFR1316.46] [Page 148] TITLE 21-FOOD AND DRUGS CHAPTER II--DRUG ENFORCEMENT ADMINISTRATION, DEPARTMENT OF JUSTICE PART 1316--ADMINISTRATIVE FUNCTIONS, PRACTICES, AND PROCEDURES--Table of Contents Subpart D--Administrative Hearings Sec. 1316.46 Inspection of record. (a) The record bearing on any proceeding, except for material described in subsection (b) of this section, shall be available for inspection and copying by any person entitled to participate in such proceeding, during office hours in the office of the Hearing Clerk, Drug Enforcement Administration, Department of Justice, Washington, DC 20537. (b) The following material shall not be available for inspection as part of the record: (1) A research protocol filed with an application for registration to conduct research with controlled substances listed in Schedule I, pursuant to Sec. 1301.32 (a)(6) of this chapter, if the applicant requests that the protocol be kept confidential; (2) An outline of a production or manufacturing process filed with an application for registration to manufacture a new narcotic controlled substance, pursuant to Sec. 1301.33 of this chapter, if the applicant requests that the outline be kept confidential; (3) Any confidential or trade secret information disclosed in conjunction with an application for registration, or in reports filed while registered, or acquired in the course of an investigation, entitled to protection under subsection 402(a) (8) of the Act (21 U.S.C. 842(a) (8)) or any other law restricting public disclosure of information; and (4) Any material contained in any investigatory report, memorandum, or file, or case report compiled by the Administration. [36 FR 7820, Apr. 24, 1971. Redesignated at 38 FR 26609, Sept. 24, 1973, as amended at 62 FR 13970, Mar. 24, 1997]